港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

宜明昂科-B

3.180

+0.1906.35%

成交量：936.83萬

成交額：2,961.84萬

市值：13.74億

市盈率：-5.18

高：3.550

開：2.990

低：2.800

收：2.990

52周最高：16.800

52周最低：2.800

股本：4.32億

香港流通股本：4.20億

量比：3.06

換手率：2.23%

股息：- -

股息率：- -

每股收益(LYR):-0.614

淨資產收益率：-29.87%

總資產收益率：-13.80%

市淨率：1.50

市盈率(LYR):-5.18

市銷率: 7.68

資料載入中...

總覽公司新聞資訊公告

異動解讀 | 宜明昂科-B盤中大漲5.15%，III期臨床試驗完成首例患者給藥

宜明昂科-B(01541)：IMM0306治療複發性╱難治性濾泡性淋巴瘤的III期臨床試驗完成首例患者給藥

宜明昂科-B(01541)發布年度業績，收入1.54億元按年增加108.09%

宜明昂科－Ｂ(01541)股價下跌5.139%，現價港幣$4.43

阿斯达克财经

宜明昂科-B(01541)成功完成IMM01(替達派西普)用於慢性粒-單核細胞白血病(CMML)一線治療的III期臨床試驗中期分析的133例患者招募

宜明昂科－Ｂ(01541)股價下跌5.368%，現價港幣$4.76

阿斯达克财经

港股異動 | 宜明昂科-B(01541)升逾10% IMM0306治療原發性膜性腎病II期臨床獲批

宜明昂科－Ｂ(01541)股價顯著上升11.925%，現價港幣$5.35

阿斯达克财经

宜明昂科－Ｂ(01541)出現大手成交400萬股，成交價$4.9，涉資1.96千萬

阿斯达克财经

每日沽空追蹤 | 宜明昂科-B 03月11日沽空量成交8.26萬股，沽空比例為4.66%

宜明昂科-B盤中異動股價大漲5.18%報5.280港元

宜明昂科－Ｂ(01541)股價上升8.125%，現價港幣$5.19

阿斯达克财经

每日沽空追蹤 | 宜明昂科-B 03月09日沽空量成交10.24萬股，沽空比例為2.9%

宜明昂科-B盤中異動早盤大幅跳水5.64%報4.180港元

宜明昂科(01541.HK)IMM0306S新藥臨床試驗申請獲批

阿斯达克财经

宜明昂科-B：中國國家藥監局批准IMM0306皮下製劑新藥臨床試驗申請

宜明昂科－Ｂ(01541)股價大幅上升19.841%，現價港幣$4.53

阿斯达克财经

港股異動 | 宜明昂科-B(01541)拉升逾16% 阿沐瑞芙普α皮下製劑IMM0306S治療系統性紅斑狼瘡IND獲批

每日沽空追蹤 | 宜明昂科-B 03月05日沽空量成交14.4萬股，沽空比例為4.64%

宜明昂科-B（01541）2月股份變動月報表，股本維持穩定

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/01541/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01541","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"宜明昂科-B","latestPrice":3.18,"timestamp":1780387724852,"preClose":2.99,"halted":0,"volume":9368300,"delay":0,"changeRate":0.06354515050167221,"floatShares":420477305,"shares":432000000,"eps":-0.6140799084610804,"marketStatus":"未開盤","change":0.19,"latestTime":"06-02 16:08:44","open":2.99,"high":3.55,"low":2.8,"amount":29618408,"amplitude":0.250836,"askPrice":3.25,"askSize":1200,"bidPrice":3.18,"bidSize":6800,"shortable":0,"etf":0,"ttmEps":-0.6499977898993701,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1780450200000},"marketStatusCode":0,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":2.99,"openAndCloseTimeList":[[1780363800000,1780372800000],[1780376400000,1780387200000]],"volumeRatio":3.055864,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","floatShares":420477305,"roa":"-13.80%","roe":"-29.87%","lyrEps":-0.61408,"volumeRatio":3.055864,"shares":432000000,"dividePrice":0,"high":3.55,"amplitude":0.250836,"preClose":2.99,"low":2.8,"week52Low":2.8,"pbRate":"1.50","psRate":"7.68","week52High":16.8,"institutionHeld":0,"latestPrice":3.18,"committee":0.7,"eps":-0.6140799084610804,"divideRate":0,"volume":9368300,"delay":0,"ttmEps":-0.6499977898993701,"open":2.99,"prevYearClose":5.83,"prevWeekClose":2.93,"prevMonthClose":2.93,"prevQuarterClose":4.44,"fiveDayClose":3.24,"twentyDayClose":4.42,"sixtyDayClose":3.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01541\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774402200000,"name":null,"time":"","dateTimestamp":1774368000000,"actualEps":null},{"date":"2025-08-26","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-25","symbol":"01541","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"盤後","dateTimestamp":1742832000000,"actualEps":null},{"market":"HK","date":"2024-08-26","symbol":"01541","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-25","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01541\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01541\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1697558400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01541\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01541","date":"2026-06-01","current":-4.891281,"percent":0.928678,"low":-30.003263,"twenty":-17.326351,"median":-11.491308,"eighty":-6.018317,"high":-2.993766,"avg":-12.422083,"sd":7.065915,"marketCap":1290208008},"quantilePoints":[{"date":"2023-08-31","current":-17.746094,"twenty":-17.746094,"median":-17.746094,"eighty":-17.746094,"marketCap":6942262047},{"date":"2023-09-08","current":-19.116691,"twenty":-19.083294,"median":-18.655615,"eighty":-17.801139,"marketCap":7390149921},{"date":"2023-09-15","current":-24.765877,"twenty":-24.765877,"median":-19.116691,"eighty":-18.557812,"marketCap":9648251285},{"date":"2023-09-22","current":-25.548224,"twenty":-25.200205,"median":-24.360534,"eighty":-18.753419,"marketCap":9909519212},{"date":"2023-09-29","current":-29.804324,"twenty":-26.447668,"median":-24.870232,"eighty":-19.083294,"marketCap":11580180660},{"date":"2023-10-06","current":-24.76052,"twenty":-26.458287,"median":-24.870232,"eighty":-19.110012,"marketCap":9615852761},{"date":"2023-10-13","current":-27.113287,"twenty":-26.458287,"median":-25.206314,"eighty":-22.322253,"marketCap":10513831229},{"date":"2023-10-20","current":-26.768577,"twenty":-26.795293,"median":-25.37532,"eighty":-23.788881,"marketCap":10364168151},{"date":"2023-10-27","current":-28.665306,"twenty":-27.124745,"median":-25.753577,"eighty":-24.00727,"marketCap":11093775656},{"date":"2023-11-03","current":-26.275244,"twenty":-27.500238,"median":-26.158488,"eighty":-24.473108,"marketCap":10195797188},{"date":"2023-11-10","current":-26.039628,"twenty":-27.37617,"median":-26.041732,"eighty":-24.763734,"marketCap":10102257765},{"date":"2023-11-17","current":-26.714897,"twenty":-27.225983,"median":-26.171076,"eighty":-24.792429,"marketCap":10457707575},{"date":"2023-11-24","current":-27.539565,"twenty":-27.37617,"median":-26.271304,"eighty":-24.846191,"marketCap":10869281039},{"date":"2023-12-01","current":-28.464343,"twenty":-27.564693,"median":-26.306056,"eighty":-24.874164,"marketCap":11280854504},{"date":"2023-12-08","current":-27.67933,"twenty":-27.70336,"median":-26.447668,"eighty":-25.070837,"marketCap":10925404694},{"date":"2023-12-15","current":-27.708906,"twenty":-27.817253,"median":-26.526325,"eighty":-25.207536,"marketCap":11000236233},{"date":"2023-12-22","current":-27.916049,"twenty":-27.937914,"median":-26.714897,"eighty":-25.244891,"marketCap":11075067772},{"date":"2023-12-29","current":-28.049426,"twenty":-27.986303,"median":-26.835368,"eighty":-25.288293,"marketCap":11187315080},{"date":"2024-01-05","current":-23.146888,"twenty":-27.970711,"median":-26.68937,"eighty":-25.200205,"marketCap":9166863527},{"date":"2024-01-12","current":-26.439512,"twenty":-27.935571,"median":-26.500765,"eighty":-25.200205,"marketCap":10476415460},{"date":"2024-01-19","current":-25.435754,"twenty":-27.916049,"median":-26.490281,"eighty":-25.212424,"marketCap":10064841995},{"date":"2024-01-26","current":-23.636611,"twenty":-27.83997,"median":-26.442842,"eighty":-24.972615,"marketCap":9316526605},{"date":"2024-02-02","current":-21.195554,"twenty":-27.817533,"median":-26.372788,"eighty":-24.783518,"marketCap":8343716598},{"date":"2024-02-09","current":-18.727145,"twenty":-27.802108,"median":-26.275244,"eighty":-24.041989,"marketCap":7408322361},{"date":"2024-02-16","current":-17.739662,"twenty":-27.801452,"median":-26.252628,"eighty":-23.794995,"marketCap":7019198358},{"date":"2024-02-23","current":-22.387155,"twenty":-27.764049,"median":-26.165159,"eighty":-23.13759,"marketCap":8811413717},{"date":"2024-03-01","current":-17.708555,"twenty":-27.735275,"median":-26.04068,"eighty":-22.460898,"marketCap":6974299434},{"date":"2024-03-08","current":-19.229551,"twenty":-27.718352,"median":-26.025076,"eighty":-21.141323,"marketCap":7576693323},{"date":"2024-03-15","current":-16.157629,"twenty":-27.69116,"median":-25.695795,"eighty":-19.998834,"marketCap":6360680815},{"date":"2024-03-22","current":-15.411367,"twenty":-27.66021,"median":-25.548224,"eighty":-19.057216,"marketCap":6061354659},{"date":"2024-03-28","current":-14.696214,"twenty":-27.629432,"median":-25.408294,"eighty":-18.737655,"marketCap":6038905197},{"date":"2024-04-05","current":-13.011166,"twenty":-27.602384,"median":-25.364375,"eighty":-18.557812,"marketCap":5342971884},{"date":"2024-04-12","current":-13.094845,"twenty":-27.539565,"median":-25.225009,"eighty":-18.239836,"marketCap":5380387654},{"date":"2024-04-19","current":-13.014894,"twenty":-27.51439,"median":-25.154554,"eighty":-17.708555,"marketCap":5342971884},{"date":"2024-04-26","current":-13.779237,"twenty":-27.443648,"median":-24.972615,"eighty":-16.602696,"marketCap":5649781194},{"date":"2024-05-03","current":-12.839078,"twenty":-27.434442,"median":-24.870232,"eighty":-16.184677,"marketCap":5260657191},{"date":"2024-05-10","current":-13.282389,"twenty":-27.357513,"median":-24.774698,"eighty":-14.702373,"marketCap":5455219193},{"date":"2024-05-17","current":-13.228926,"twenty":-27.225983,"median":-24.581805,"eighty":-14.243189,"marketCap":5425286577},{"date":"2024-05-24","current":-13.350651,"twenty":-27.145452,"median":-23.955191,"eighty":-13.966896,"marketCap":5462702347},{"date":"2024-05-31","current":-13.410156,"twenty":-27.124745,"median":-23.750163,"eighty":-13.747349,"marketCap":5492634962},{"date":"2024-06-07","current":-14.158514,"twenty":-27.039336,"median":-23.288627,"eighty":-13.645876,"marketCap":5791961118},{"date":"2024-06-14","current":-13.347574,"twenty":-26.971042,"median":-23.123643,"eighty":-13.527845,"marketCap":5455219193},{"date":"2024-06-21","current":-13.283836,"twenty":-26.926395,"median":-22.448608,"eighty":-13.452996,"marketCap":5417803423},{"date":"2024-06-28","current":-12.683619,"twenty":-26.848726,"median":-21.974147,"eighty":-13.40419,"marketCap":5170859344},{"date":"2024-07-05","current":-11.291057,"twenty":-26.759122,"median":-21.059976,"eighty":-13.359292,"marketCap":4602139648},{"date":"2024-07-12","current":-12.246119,"twenty":-26.720023,"median":-20.206581,"eighty":-13.323498,"marketCap":4998746805},{"date":"2024-07-19","current":-11.915911,"twenty":-26.704686,"median":-19.229551,"eighty":-13.282563,"marketCap":4864050035},{"date":"2024-07-26","current":-11.780484,"twenty":-26.652155,"median":-19.050696,"eighty":-13.224977,"marketCap":4826634265},{"date":"2024-08-02","current":-13.633124,"twenty":-26.594701,"median":-18.753419,"eighty":-13.20236,"marketCap":5582432809},{"date":"2024-08-09","current":-9.567144,"twenty":-26.54166,"median":-18.630761,"eighty":-13.102374,"marketCap":3943622105},{"date":"2024-08-16","current":-8.483685,"twenty":-26.496571,"median":-18.451463,"eighty":-13.086665,"marketCap":3498374448},{"date":"2024-08-23","current":-8.095604,"twenty":-26.47337,"median":-18.020488,"eighty":-13.035717,"marketCap":3352452947},{"date":"2024-08-30","current":-7.377309,"twenty":-26.446703,"median":-17.739662,"eighty":-12.990136,"marketCap":3034418906},{"date":"2024-09-06","current":-4.227864,"twenty":-26.442176,"median":-17.681919,"eighty":-12.840212,"marketCap":1739833281},{"date":"2024-09-13","current":-4.503325,"twenty":-26.43833,"median":-16.602696,"eighty":-12.741292,"marketCap":1848339013},{"date":"2024-09-20","current":-4.539912,"twenty":-26.433601,"median":-16.202037,"eighty":-12.246119,"marketCap":1874530051},{"date":"2024-09-27","current":-5.476578,"twenty":-26.311976,"median":-15.844451,"eighty":-11.915911,"marketCap":2274878785},{"date":"2024-10-04","current":-6.596451,"twenty":-26.302504,"median":-15.05764,"eighty":-11.832338,"marketCap":2727609596},{"date":"2024-10-10","current":-5.983695,"twenty":-26.285201,"median":-14.496802,"eighty":-11.807116,"marketCap":2458216056},{"date":"2024-10-18","current":-5.191078,"twenty":-26.27288,"median":-14.209972,"eighty":-11.719903,"marketCap":2121474130},{"date":"2024-10-25","current":-7.104995,"twenty":-26.248892,"median":-14.119017,"eighty":-11.287262,"marketCap":2903463713},{"date":"2024-11-01","current":-6.615271,"twenty":-26.199776,"median":-13.881638,"eighty":-9.764235,"marketCap":2705160134},{"date":"2024-11-08","current":-6.847628,"twenty":-26.169892,"median":-13.803075,"eighty":-8.441853,"marketCap":2787474827},{"date":"2024-11-15","current":-7.078843,"twenty":-26.118271,"median":-13.690467,"eighty":-8.248986,"marketCap":2851081635},{"date":"2024-11-22","current":-6.784782,"twenty":-26.059844,"median":-13.633178,"eighty":-7.853303,"marketCap":2731351173},{"date":"2024-11-29","current":-5.682581,"twenty":-26.04047,"median":-13.539989,"eighty":-7.45767,"marketCap":2286103516},{"date":"2024-12-06","current":-5.602773,"twenty":-26.037499,"median":-13.514674,"eighty":-7.358253,"marketCap":2248687746},{"date":"2024-12-13","current":-6.121403,"twenty":-26.029477,"median":-13.45004,"eighty":-7.218028,"marketCap":2451992323},{"date":"2024-12-20","current":-5.137492,"twenty":-25.962318,"median":-13.411134,"eighty":-7.087735,"marketCap":2048757705},{"date":"2024-12-27","current":-4.957491,"twenty":-25.887099,"median":-13.400213,"eighty":-7.078006,"marketCap":1975442320},{"date":"2025-01-03","current":-5.238569,"twenty":-25.753577,"median":-13.368079,"eighty":-6.925822,"marketCap":2089488475},{"date":"2025-01-10","current":-5.002231,"twenty":-25.638014,"median":-13.3526,"eighty":-6.765934,"marketCap":1987661551},{"date":"2025-01-17","current":-5.018682,"twenty":-25.5579,"median":-13.317479,"eighty":-6.665777,"marketCap":1995807705},{"date":"2025-01-24","current":-5.323319,"twenty":-25.548224,"median":-13.283546,"eighty":-6.596451,"marketCap":2130219244},{"date":"2025-01-28","current":-5.224689,"twenty":-25.503236,"median":-13.282823,"eighty":-6.532117,"marketCap":2101707706},{"date":"2025-02-07","current":-5.549725,"twenty":-25.42477,"median":-13.246663,"eighty":-6.254752,"marketCap":2219826937},{"date":"2025-02-14","current":-5.930475,"twenty":-25.395104,"median":-13.220128,"eighty":-6.076947,"marketCap":2366457707},{"date":"2025-02-21","current":-6.375256,"twenty":-25.366564,"median":-13.201126,"eighty":-6.054191,"marketCap":2557892324},{"date":"2025-02-28","current":-5.632443,"twenty":-25.318672,"median":-13.116805,"eighty":-5.974648,"marketCap":2252411553},{"date":"2025-03-07","current":-5.782376,"twenty":-25.249925,"median":-13.099044,"eighty":-5.827424,"marketCap":2321653861},{"date":"2025-03-14","current":-4.421401,"twenty":-25.219975,"median":-13.087912,"eighty":-5.725677,"marketCap":1775861550},{"date":"2025-03-21","current":-4.778207,"twenty":-25.207536,"median":-13.071662,"eighty":-5.66584,"marketCap":1918419243},{"date":"2025-03-28","current":-6.735516,"twenty":-25.163684,"median":-13.026305,"eighty":-5.651503,"marketCap":2276850015},{"date":"2025-04-03","current":-7.956153,"twenty":-25.0977,"median":-13.01303,"eighty":-5.66026,"marketCap":2684157710},{"date":"2025-04-11","current":-6.344288,"twenty":-25.036833,"median":-12.972072,"eighty":-5.68428,"marketCap":2126146167},{"date":"2025-04-17","current":-6.122985,"twenty":-24.972615,"median":-12.844749,"eighty":-5.691075,"marketCap":2056903859},{"date":"2025-04-25","current":-8.576896,"twenty":-24.895951,"median":-12.836736,"eighty":-5.703559,"marketCap":2883738480},{"date":"2025-05-02","current":-7.700417,"twenty":-24.872853,"median":-12.82514,"eighty":-5.710649,"marketCap":2594550017},{"date":"2025-05-09","current":-7.730765,"twenty":-24.846191,"median":-12.683619,"eighty":-5.725677,"marketCap":2623061555},{"date":"2025-05-16","current":-8.311097,"twenty":-24.799485,"median":-12.12195,"eighty":-5.751942,"marketCap":2843007711},{"date":"2025-05-23","current":-11.289802,"twenty":-24.776462,"median":-11.940532,"eighty":-5.771038,"marketCap":3873496179},{"date":"2025-05-30","current":-15.223569,"twenty":-24.763734,"median":-11.970101,"eighty":-5.797425,"marketCap":5246123111},{"date":"2025-06-06","current":-16.623143,"twenty":-24.617548,"median":-12.331836,"eighty":-5.827424,"marketCap":5743038499},{"date":"2025-06-13","current":-15.603079,"twenty":-24.258649,"median":-12.701975,"eighty":-5.862056,"marketCap":5392753881},{"date":"2025-06-20","current":-14.878015,"twenty":-24.00727,"median":-12.82804,"eighty":-5.90109,"marketCap":5132076957},{"date":"2025-06-27","current":-13.023121,"twenty":-23.933348,"median":-12.837907,"eighty":-5.91626,"marketCap":4504823106},{"date":"2025-07-04","current":-14.906416,"twenty":-23.89321,"median":-12.895238,"eighty":-5.935244,"marketCap":5156515418},{"date":"2025-07-11","current":-12.022018,"twenty":-23.818294,"median":-12.972072,"eighty":-5.957179,"marketCap":4154538489},{"date":"2025-07-18","current":-12.975089,"twenty":-23.597552,"median":-12.895238,"eighty":-5.971632,"marketCap":4480384645},{"date":"2025-07-25","current":-12.316929,"twenty":-23.410778,"median":-12.839078,"eighty":-5.984465,"marketCap":4268584643},{"date":"2025-08-01","current":-12.109688,"twenty":-23.260279,"median":-12.895238,"eighty":-5.992729,"marketCap":4170830796},{"date":"2025-08-08","current":-13.046774,"twenty":-23.142239,"median":-12.972072,"eighty":-6.013995,"marketCap":4504823106},{"date":"2025-08-15","current":-15.594562,"twenty":-23.052783,"median":-12.982136,"eighty":-6.023266,"marketCap":5376461574},{"date":"2025-08-22","current":-14.245172,"twenty":-22.717488,"median":-13.011166,"eighty":-6.052989,"marketCap":4895838493},{"date":"2025-08-29","current":-13.416028,"twenty":-22.485479,"median":-13.022379,"eighty":-6.061027,"marketCap":4439653875},{"date":"2025-09-05","current":-17.224047,"twenty":-22.314693,"median":-13.032106,"eighty":-6.075447,"marketCap":5694161576},{"date":"2025-09-12","current":-15.065483,"twenty":-22.014704,"median":-13.063177,"eighty":-6.087386,"marketCap":4989519263},{"date":"2025-09-19","current":-14.903882,"twenty":-21.818428,"median":-13.085834,"eighty":-6.113201,"marketCap":4932496186},{"date":"2025-09-26","current":-13.980202,"twenty":-21.168438,"median":-13.096763,"eighty":-6.121719,"marketCap":4614796184},{"date":"2025-10-03","current":-19.067762,"twenty":-21.059976,"median":-13.099741,"eighty":-6.122985,"marketCap":6309196195},{"date":"2025-10-10","current":-15.483575,"twenty":-20.658991,"median":-13.109708,"eighty":-6.128239,"marketCap":5115784649},{"date":"2025-10-17","current":-12.892469,"twenty":-20.520951,"median":-13.123492,"eighty":-6.17051,"marketCap":4256365412},{"date":"2025-10-24","current":-11.824326,"twenty":-20.411262,"median":-13.104868,"eighty":-6.183537,"marketCap":3905144639},{"date":"2025-10-31","current":-11.96327,"twenty":-20.170656,"median":-13.098863,"eighty":-6.223751,"marketCap":3956925563},{"date":"2025-11-07","current":-10.312858,"twenty":-19.984772,"median":-13.08999,"eighty":-6.257081,"marketCap":3408910790},{"date":"2025-11-14","current":-10.296734,"twenty":-19.520389,"median":-13.071805,"eighty":-6.311268,"marketCap":3413225867},{"date":"2025-11-21","current":-8.92105,"twenty":-19.161835,"median":-13.046774,"eighty":-6.362869,"marketCap":2955827710},{"date":"2025-11-28","current":-9.407815,"twenty":-19.096653,"median":-13.027047,"eighty":-6.414675,"marketCap":3128430788},{"date":"2025-12-05","current":-8.666243,"twenty":-19.073975,"median":-13.014894,"eighty":-6.44644,"marketCap":2886786479},{"date":"2025-12-12","current":-8.404571,"twenty":-19.037964,"median":-12.986335,"eighty":-6.450097,"marketCap":2804800017},{"date":"2025-12-19","current":-8.049417,"twenty":-18.988805,"median":-12.975089,"eighty":-6.476679,"marketCap":2692608016},{"date":"2025-12-24","current":-7.972984,"twenty":-18.926105,"median":-12.9589,"eighty":-6.505915,"marketCap":2675347709},{"date":"2026-01-02","current":-7.788017,"twenty":-18.753419,"median":-12.908879,"eighty":-6.55197,"marketCap":2623566785},{"date":"2026-01-09","current":-8.075331,"twenty":-18.727145,"median":-12.839078,"eighty":-6.58869,"marketCap":2727128632},{"date":"2026-01-16","current":-7.93455,"twenty":-18.70371,"median":-12.833897,"eighty":-6.596451,"marketCap":2688292939},{"date":"2026-01-23","current":-6.093671,"twenty":-18.557812,"median":-12.82514,"eighty":-6.55197,"marketCap":2062606782},{"date":"2026-01-30","current":-5.748685,"twenty":-18.530718,"median":-12.736832,"eighty":-6.440954,"marketCap":1954729858},{"date":"2026-02-06","current":-5.480977,"twenty":-18.467104,"median":-12.547098,"eighty":-6.250095,"marketCap":1868428319},{"date":"2026-02-13","current":-5.764322,"twenty":-18.451463,"median":-12.334661,"eighty":-6.129552,"marketCap":1976305243},{"date":"2026-02-20","current":-5.709616,"twenty":-18.447248,"median":-12.324382,"eighty":-6.122036,"marketCap":1954729858},{"date":"2026-02-27","current":-5.173921,"twenty":-18.36049,"median":-12.246119,"eighty":-6.086335,"marketCap":1790756934},{"date":"2026-03-06","current":-5.567891,"twenty":-18.158064,"median":-12.065853,"eighty":-6.054191,"marketCap":1911579088},{"date":"2026-03-13","current":-6.117869,"twenty":-18.015354,"median":-11.997781,"eighty":-6.054191,"marketCap":2110072628},{"date":"2026-03-20","current":-5.927628,"twenty":-17.916043,"median":-11.941476,"eighty":-6.046952,"marketCap":2036716320},{"date":"2026-03-27","current":-7.775976,"twenty":-17.807771,"median":-11.897801,"eighty":-5.998519,"marketCap":1924524319},{"date":"2026-04-02","current":-8.241979,"twenty":-17.7975,"median":-11.83436,"eighty":-6.013995,"marketCap":2049661551},{"date":"2026-04-10","current":-8.161679,"twenty":-17.786583,"median":-11.824288,"eighty":-6.015601,"marketCap":2045346474},{"date":"2026-04-17","current":-10.223634,"twenty":-17.753464,"median":-11.822864,"eighty":-6.03821,"marketCap":2563155708},{"date":"2026-04-24","current":-8.708527,"twenty":-17.740948,"median":-11.788146,"eighty":-6.050175,"marketCap":2183428936},{"date":"2026-04-30","current":-8.01805,"twenty":-17.720998,"median":-11.771721,"eighty":-6.055393,"marketCap":2010825858},{"date":"2026-05-08","current":-7.201573,"twenty":-17.693999,"median":-11.728007,"eighty":-6.067488,"marketCap":1812332319},{"date":"2026-05-15","current":-6.019771,"twenty":-17.681444,"median":-11.664585,"eighty":-6.067488,"marketCap":1518907086},{"date":"2026-05-22","current":-5.845011,"twenty":-17.559701,"median":-11.603261,"eighty":-6.055393,"marketCap":1471441239},{"date":"2026-05-29","current":-5.00485,"twenty":-17.377503,"median":-11.514742,"eighty":-6.021369,"marketCap":1264317546},{"date":"2026-06-01","current":-5.096104,"twenty":-17.326351,"median":-11.491308,"eighty":-6.018317,"marketCap":1290208008}],"updateTime":1780415796453},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01541\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1102540356","title":"異動解讀 | 宜明昂科-B盤中大漲5.15%，III期臨床試驗完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=1102540356","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102540356?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 10:02","pubTimestamp":1774922528,"startTime":"0","endTime":"0","summary":"宜明昂科-B今日盘中股价大幅上涨5.15%，引起了市场的广泛关注。消息面上，公司发布公告称，其独立研发的IMM0306联合来那度胺治疗复发性╱难治性滤泡性淋巴瘤的III期临床试验，已顺利完成首例患者给药。根据公告，IMM0306通过独特的机制阻断“别吃我”信号，激活免疫细胞以消除恶性B细胞，同时旨在降低毒性，改善治疗效果。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623347904","title":"宜明昂科-B(01541)：IMM0306治療複發性╱難治性濾泡性淋巴瘤的III期臨床試驗完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2623347904","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623347904?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 00:28","pubTimestamp":1774888085,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B 发布公告，IMM0306联合来那度胺治疗复发性╱难治性滤泡性淋巴瘤的III期临床试验顺利完成首例患者给药。由本集团独立研发的IMM0306是一种靶向分化簇47 及分化簇20 的双特异性分子，是全球首个进入临床阶段的CD47和CD20双靶向双特异性分子。截至本公告日期，本集团拥有IMM0306的全球知识产权及商业化权利。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","BK1161","BK4134","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622072960","title":"宜明昂科-B(01541)發布年度業績，收入1.54億元 按年增加108.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622072960","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622072960?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 22:21","pubTimestamp":1774448474,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B 发布截至2025年12月31日止年度业绩，该公司取得收入人民币1.54亿元，同比增加108.09%;本公司股东应占年内亏损人民币2.19亿元，同比收窄30.8%;毛利人民币1.53亿元，同比增加106.59%;每股亏损人民币0.53元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419070.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622049868","title":"宜明昂科－Ｂ(01541)股價下跌5.139%，現價港幣$4.43","url":"https://stock-news.laohu8.com/highlight/detail?id=2622049868","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622049868?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 11:49","pubTimestamp":1774410540,"startTime":"0","endTime":"0","summary":"[下跌股]宜明昂科－Ｂ(01541) 股价在上午11:49比前收市价下跌5.139%，现股价为港币$4.43。至目前为止，今日最高价为$4.74，而最低价为$4.43。总成交量为41.94万股，总成交金额为港币$191.674万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603251551/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603251551/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621742594","title":"宜明昂科-B(01541)成功完成IMM01(替達派西普)用於慢性粒-單核細胞白血病(CMML)一線治療的III期臨床試驗中期分析的133例患者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=2621742594","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621742594?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 07:22","pubTimestamp":1774221759,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B 发布公告，本公司成功完成IMM01用于慢性粒-单核细胞白血病一线治疗的III期临床试验中期分析的133例患者招募。此外，IMM01的CD47结合结构域经过特别改造能够避免与人体红细胞结合。凭藉差异化的分子设计，IMM01表现出良好的安全性并证实其激活巨噬细胞的能力。IMM01联合阿扎胞苷进行CMML一线治疗于2023年11月获美国食品药品监督管理局授予的孤儿药资格认定。本集团拥有IMM01的全球知识产权及商业化权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417114.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01541","BK4134","III","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620200210","title":"宜明昂科－Ｂ(01541)股價下跌5.368%，現價港幣$4.76","url":"https://stock-news.laohu8.com/highlight/detail?id=2620200210","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620200210?lang=zh_tw&edition=fundamental","pubTime":"2026-03-20 14:30","pubTimestamp":1773988200,"startTime":"0","endTime":"0","summary":"[下跌股]宜明昂科－Ｂ(01541) 股价在下午02:30比前收市价下跌5.368%，现股价为港币$4.76。至目前为止，今日最高价为$5.16，而最低价为$4.76。总成交量为56.62万股，总成交金额为港币$277.973万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603202812/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603202812/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620283973","title":"港股異動 | 宜明昂科-B(01541)升逾10% IMM0306治療原發性膜性腎病II期臨床獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2620283973","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620283973?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 10:48","pubTimestamp":1773802081,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，宜明昂科-B涨超10%，截至发稿，涨10.46%，报5.28港元，成交额703.34万港元。消息面上，3月17日，宜明昂科宣布，公司自主研发的阿沐瑞芙普α治疗原发性膜性肾病的II期临床研究已正式获得国家药品监督管理局批准。公司表示，此次IMM0306在治疗原发性膜性肾病适应症上的II期临床获批，连同近期阿沐瑞芙普α皮下注射制剂，是宜明昂科在自身免疫性疾病领域密集布局的最新成果，也是公司“自免管线多点突破”战略的重要体现。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415259.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","VXUS","01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620428869","title":"宜明昂科－Ｂ(01541)股價顯著上升11.925%，現價港幣$5.35","url":"https://stock-news.laohu8.com/highlight/detail?id=2620428869","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620428869?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 09:50","pubTimestamp":1773798600,"startTime":"0","endTime":"0","summary":"[上升股]宜明昂科－Ｂ(01541) 股价在上午09:50比前收市价显著上升11.925%，现股价为港币$5.35。至目前为止，今日最高价为$5.35，而最低价为$4.9。总成交量为58.46万股，总成交金额为港币$300.679万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260318377/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260318377/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620741657","title":"宜明昂科－Ｂ(01541)出現大手成交400萬股，成交價$4.9，涉資1.96千萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2620741657","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620741657?lang=zh_tw&edition=fundamental","pubTime":"2026-03-17 09:02","pubTimestamp":1773709320,"startTime":"0","endTime":"0","summary":"[大手成交]宜明昂科－Ｂ(01541)在上午09:02出现大手成交，成交量为400万，成交价为港币$4.9，涉资1.96千万。至目前为止，股价无升跌，今日最高价为$4.9，而最低价为$4.9，总成交量为400万股，总成交金额港币$1.96千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145549237_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145549237_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603172/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603172/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618402919","title":"每日沽空追蹤 | 宜明昂科-B 03月11日沽空量成交8.26萬股，沽空比例為4.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618402919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618402919?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 16:30","pubTimestamp":1773217822,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间03月11日，涨6.97%，卖空量成交8.26万股，较上一交易日减少41.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163245a6b793fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163245a6b793fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618265940","title":"宜明昂科-B盤中異動 股價大漲5.18%報5.280港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618265940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618265940?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 10:08","pubTimestamp":1773194894,"startTime":"0","endTime":"0","summary":"2026年03月11日早盘10时08分，宜明昂科-B股票出现波动，股价急速拉升5.18%。截至发稿，该股报5.280港元/股，成交量36.34万股，换手率0.09%，振幅4.98%。资金方面，该股资金流入94.761万港元，流出62.7388万港元。宜明昂科-B股票所在的生物技术行业中，整体跌幅为1.20%。其相关个股中，中慧生物-B、加科思-B、创胜集团-B涨幅较大，振幅较大的相关个股有中慧生物-B、科济药业-B、映恩生物-B，振幅分别为18.33%、9.06%、8.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311100814a45fdbd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311100814a45fdbd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618604981","title":"宜明昂科－Ｂ(01541)股價上升8.125%，現價港幣$5.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2618604981","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618604981?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 09:55","pubTimestamp":1773107700,"startTime":"0","endTime":"0","summary":"[上升股]宜明昂科－Ｂ(01541) 股价在上午09:55比前收市价上升8.125%，现股价为港币$5.19。至目前为止，今日最高价为$5.19，而最低价为$4.68。总成交量为70.56万股，总成交金额为港币$350.637万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603102648/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603102648/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618762920","title":"每日沽空追蹤 | 宜明昂科-B 03月09日沽空量成交10.24萬股，沽空比例為2.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618762920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618762920?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 16:30","pubTimestamp":1773045022,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间03月09日，涨8.35%，卖空量成交10.24万股，较上一交易日减少14.24%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163243a45ae67c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163243a45ae67c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618629787","title":"宜明昂科-B盤中異動 早盤大幅跳水5.64%報4.180港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618629787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618629787?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 09:31","pubTimestamp":1773019883,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时31分，宜明昂科-B股票出现异动，股价快速下跌5.64%。截至发稿，该股报4.180港元/股，成交量3.78万股，换手率0.01%，振幅6.32%。资金方面，该股资金流入0港元，流出14.7022万港元。宜明昂科-B股票所在的生物技术行业中，整体跌幅为1.93%。其相关个股中，科济药业-B、派格生物医药-B、维立志博-B涨幅较大，振幅较大的相关个股有科济药业-B、药捷安康-B、派格生物医药-B，振幅分别为15.55%、9.51%、8.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093123a6b082cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093123a6b082cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617667317","title":"宜明昂科(01541.HK)IMM0306S新藥臨床試驗申請獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2617667317","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617667317?lang=zh_tw&edition=fundamental","pubTime":"2026-03-08 20:06","pubTimestamp":1772971560,"startTime":"0","endTime":"0","summary":"宜明昂科－Ｂ(01541.HK) 公布，集团已获得中国国家药监局批准，IMM0306S(皮下制剂)治疗系统性红斑狼疮(SLE)的新药临床试验申请。目前，集团拥有IMM0306S的全球知识产权及商业化权利。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2026-03-06 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230915102623267_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230915102623267_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1507403/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1507403/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195005004","title":"宜明昂科-B：中國國家藥監局批准IMM0306皮下製劑新藥臨床試驗申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1195005004","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195005004?lang=zh_tw&edition=fundamental","pubTime":"2026-03-06 22:05","pubTimestamp":1772805914,"startTime":"0","endTime":"0","summary":"宜明昂科-B宣布，其IMM0306皮下制剂的新药临床试验申请已获得中国国家药品监督管理局的批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617047555","title":"宜明昂科－Ｂ(01541)股價大幅上升19.841%，現價港幣$4.53","url":"https://stock-news.laohu8.com/highlight/detail?id=2617047555","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617047555?lang=zh_tw&edition=fundamental","pubTime":"2026-03-06 13:35","pubTimestamp":1772775300,"startTime":"0","endTime":"0","summary":"[上升股]宜明昂科－Ｂ(01541) 股价在下午01:35比前收市价大幅上升19.841%，现股价为港币$4.53。至目前为止，今日最高价为$4.53，而最低价为$3.96。总成交量为303.02万股，总成交金额为港币$1.299千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603066183/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603066183/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617509266","title":"港股異動 | 宜明昂科-B(01541)拉升逾16% 阿沐瑞芙普α皮下製劑IMM0306S治療系統性紅斑狼瘡IND獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2617509266","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617509266?lang=zh_tw&edition=fundamental","pubTime":"2026-03-06 11:47","pubTimestamp":1772768845,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，宜明昂科-B拉升逾16%，截至发稿，涨15.87%，报4.38港元，成交额947.17万港元。消息面上，3月4日，据宜明昂科官微消息，公司宣布，自主研发的阿沐瑞芙普α皮下注射制剂，用于治疗系统性红斑狼疮的临床试验申请已获得中国国家药品监督管理局的正式批准。此次阿沐瑞芙普α皮下注射制剂治疗系统性红斑狼疮的IND获批，是宜明昂科在自身免疫性疾病领域密集布局的最新成果，也是其“自免管线全面开花”战略的重要体现。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","IND","VXUS","BK1161","VT","01541","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617573033","title":"每日沽空追蹤 | 宜明昂科-B 03月05日沽空量成交14.4萬股，沽空比例為4.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617573033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617573033?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 16:30","pubTimestamp":1772699423,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间03月05日，涨8.93%，卖空量成交14.4万股，较上一交易日增加352.83%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163242a44ef682&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163242a44ef682&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189504472","title":"宜明昂科-B（01541）2月股份變動月報表，股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1189504472","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189504472?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 10:45","pubTimestamp":1772678759,"startTime":"0","endTime":"0","summary":"宜明昂科生物医药技术（上海）股份有限公司于2026年3月5日发布2月证券变动月报表。公告显示，截至2026年2月28日，公司注册股本总额为人民币431,507,695元，包含已在香港联交所上市的H股420,477,305股和未在香港联交所上市的其他股份11,030,390股，面值均为每股人民币1元。H股及非上市股份数目分别维持在420,477,305股及11,030,390股，库藏股数目为0股。公司在报告中确认已满足香港联交所上市规则对于公众持股量的要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":125,"code":"91000000","status":"200"}]}}